BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22661090)

  • 1. Comprehensive analysis of CD4+ T cells in the decision between tolerance and immunity in vivo reveals a pivotal role for ICOS.
    Lischke T; Hegemann A; Gurka S; Vu Van D; Burmeister Y; Lam KP; Kershaw O; Mollenkopf HJ; Mages HW; Hutloff A; Kroczek RA
    J Immunol; 2012 Jul; 189(1):234-44. PubMed ID: 22661090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance.
    Busse M; Krech M; Meyer-Bahlburg A; Hennig C; Hansen G
    J Immunol; 2012 Aug; 189(4):1975-82. PubMed ID: 22815292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
    Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
    J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Default" generation of neonatal regulatory T cells.
    Wang G; Miyahara Y; Guo Z; Khattar M; Stepkowski SM; Chen W
    J Immunol; 2010 Jul; 185(1):71-8. PubMed ID: 20498359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
    Mascarell L; Lombardi V; Zimmer A; Louise A; Tourdot S; Van Overtvelt L; Moingeon P
    Clin Exp Allergy; 2009 Dec; 39(12):1910-9. PubMed ID: 19694757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
    Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
    Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
    Marks E; Verolin M; Stensson A; Lycke N
    Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T cells through the ICOSL/ICOS axis.
    Nie X; Cai G; Zhang W; Wang H; Wu B; Li Q; Shen Q
    Clin Immunol; 2012 Mar; 142(3):269-79. PubMed ID: 22154192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
    Sun JB; Czerkinsky C; Holmgren J
    Scand J Immunol; 2007; 66(2-3):278-86. PubMed ID: 17635805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
    Huang H; Dawicki W; Zhang X; Town J; Gordon JR
    J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness.
    Ahangarani RR; Janssens W; VanderElst L; Carlier V; VandenDriessche T; Chuah M; Weynand B; Vanoirbeek JA; Jacquemin M; Saint-Remy JM
    J Immunol; 2009 Dec; 183(12):8232-43. PubMed ID: 20007587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice.
    Kornete M; Sgouroudis E; Piccirillo CA
    J Immunol; 2012 Feb; 188(3):1064-74. PubMed ID: 22227569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of T-cell expansion caused by inducible costimulator/B7h costimulation blockade in direct allorecognition pathway.
    Du JF; Li QY; Ji XQ; Chen G; Bai X; Zuo FY; Yu B
    Transplant Proc; 2011 Dec; 43(10):3960-3. PubMed ID: 22172879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.